Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs| Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) | Delayed: 34.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.70 | 52 Week High | $34.07 | |||
| Open | $34.70 | 52 Week Low | $21.84 | |||
| Day High | $34.70 | P/E | N/A | |||
| Day Low | $34.70 | EPS | $0.00 | |||
| Volume | 2 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 609.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $609.94 | 52 Week High | $592.36 | |||
| Open | $609.94 | 52 Week Low | $325.35 | |||
| Day High | $609.94 | P/E | 160.09 | |||
| Day Low | $609.94 | EPS | $3.81 | |||
| Volume | 1,315 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 31.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.48 | 52 Week High | $66.55 | |||
| Open | $31.48 | 52 Week Low | $37.82 | |||
| Day High | $31.48 | P/E | N/A | |||
| Day Low | $31.48 | EPS | $0.00 | |||
| Volume | 11,660 | |||||
